Daylight Solutions Signs Definitive Agreement with Leonardo DRS

06:03 EST 9 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Daylight Solutions, Inc. (Daylight), a world leader in mid-infrared lasers and systems based on its proprietary quantum cascade laser (QCL) technologies, along with Leonardo S.p.A., through its U.S. subsidiary Leonardo DRS, anno...

Other Sources for this Article

Daylight Solutions, Inc.
Eric Takeuchi, 858-432-7507


More From BioPortfolio on "Daylight Solutions Signs Definitive Agreement with Leonardo DRS"

Quick Search


Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...